Mark Gardner is a seasoned executive with extensive experience in the healthcare and biotechnology sectors. Currently serving as the Senior Vice President of Genomic Medicine and Oncology at Quest Diagnostics since October 2022, Gardner has held significant leadership positions including Senior Vice President at Corza Medical and Corza Health, and Chief Executive Officer at OmniSeq Precision Medicine Technology. Earlier career roles include Vice President at Thermo Fisher Scientific and Master Black Belt at GE Healthcare. Gardner's career began in the US Navy, where Mark served from 1987 to 1996, earning commendations for exemplary service. Academic credentials include an MBA in Finance from The Wharton School and a Master's degree in National Security Policy Studies from Georgetown University.